Literature DB >> 2508730

The CD4/CD8:p56lck complex in T lymphocytes: a potential mechanism to regulate T-cell growth.

C Rudd1, S Helms, E K Barber, S F Schlossman.   

Abstract

The CD4 and CD8 antigens on the surface of T cells appear to bind to major histocompatibility complex (MHC) class II and I antigens, respectively. These receptors have also been found to regulate T cell growth in a manner independent of MHC recognition. In this report, we describe recent work showing that the CD4 and CD8 receptors are coupled to a protein-tyrosine kinase, p56lck, from T lymphocytes. The p56lck protein is a member of the src family, which plays a crucial role in the activation and transformation of various mammalian cells. The CD4/CD8:p56lck complex is catalytically active as shown by its ability to phosphorylate at 55-60 kDa. Two-dimensional, nonequilibrium gel electrophoresis demonstrated the similarity of p56lck associated with the CD4 and CD8 antigens. Detergents were found to vary in their ability to solubilize the CD4:p56lck complex in a catalytically active form. We further demonstrated by in vitro phosphorylation that members of the CD3 complex including the gamma, delta, and epsilon chains, as well as a putative zeta subunit can be phosphorylated at tyrosyl residues by the CD4/CD8:p56lck complex. Thus, this interaction may play an important role in the activation of T cells, and may mediate the cooperative interaction between the CD4/CD8 antigens and the Ti(TcR)/CD3 complex. This interaction also represents a possible precedent by which other members of the src family (c-src, c-yes, c-fgr, etc.) may be found to interact with mammalian growth receptors.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2508730     DOI: 10.1139/o89-090

Source DB:  PubMed          Journal:  Biochem Cell Biol        ISSN: 0829-8211            Impact factor:   3.626


  7 in total

1.  Glucocorticoid-mediated inhibition of Lck modulates the pattern of T cell receptor-induced calcium signals by down-regulating inositol 1,4,5-trisphosphate receptors.

Authors:  Michael W Harr; Yiping Rong; Martin D Bootman; H Llewelyn Roderick; Clark W Distelhorst
Journal:  J Biol Chem       Date:  2009-09-23       Impact factor: 5.157

2.  Impact of a CD4 gene haplotype on the immune response in minipigs.

Authors:  Fany Blanc; Françoise Créchet; Nicolas Bruneau; Guillaume Piton; Jean-Jacques Leplat; Fabrice Andréoletti; Giorgia Egidy; Silvia Vincent-Naulleau; Emmanuelle Bourneuf
Journal:  Immunogenetics       Date:  2017-10-20       Impact factor: 2.846

3.  Enhancement of antigen-induced T-cell proliferation by soluble CD26/dipeptidyl peptidase IV.

Authors:  T Tanaka; J S Duke-Cohan; J Kameoka; A Yaron; I Lee; S F Schlossman; C Morimoto
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-12       Impact factor: 11.205

4.  CD8 lineage commitment in the absence of CD8.

Authors:  A W Goldrath; K A Hogquist; M J Bevan
Journal:  Immunity       Date:  1997-05       Impact factor: 31.745

5.  Delayed thymocyte development induced by augmented expression of p56lck.

Authors:  K M Abraham; S D Levin; J D Marth; K A Forbush; R M Perlmutter
Journal:  J Exp Med       Date:  1991-06-01       Impact factor: 14.307

6.  Involvement of both major histocompatibility complex class II alpha and beta chains in CD4 function indicates a role for ordered oligomerization in T cell activation.

Authors:  R König; X Shen; R N Germain
Journal:  J Exp Med       Date:  1995-09-01       Impact factor: 14.307

Review 7.  T Cell Activation Machinery: Form and Function in Natural and Engineered Immune Receptors.

Authors:  Nicholas J Chandler; Melissa J Call; Matthew E Call
Journal:  Int J Mol Sci       Date:  2020-10-08       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.